Insider Transactions in Q1 2024 at Phoenix Biotech Acquisition Corp. (PBAXU)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Daniel E. Geffken Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
10,002
+50.0%
|
-
|
|
Feb 14
2024
|
Barbara Kosacz Director |
BUY
Other acquisition or disposition
|
Direct |
5,828
+50.0%
|
-
|
|
Feb 14
2024
|
Caroline M Loewy Director |
BUY
Other acquisition or disposition
|
Direct |
5,828
+50.0%
|
-
|
|
Feb 14
2024
|
Brian G Atwood Director |
BUY
Other acquisition or disposition
|
Indirect |
248,735
+43.67%
|
-
|
|
Feb 14
2024
|
Brian G Atwood Director |
BUY
Other acquisition or disposition
|
Direct |
125,000
+50.0%
|
-
|
|
Feb 14
2024
|
Christopher B Ehrlich Interim Chairman and CEO |
BUY
Other acquisition or disposition
|
Indirect |
3,600
+50.0%
|
-
|
|
Feb 14
2024
|
Christopher B Ehrlich Interim Chairman and CEO |
BUY
Other acquisition or disposition
|
Direct |
478,825
+50.0%
|
-
|
|
Feb 14
2024
|
Christopher B Ehrlich Interim Chairman and CEO |
SELL
Other acquisition or disposition
|
Indirect |
5,296,246
-50.95%
|
-
|
|
Feb 14
2024
|
Kathleen Laporte Director |
BUY
Other acquisition or disposition
|
Direct |
5,828
+50.0%
|
-
|
|
Feb 14
2024
|
Phoenix Biotech Sponsor, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
5,296,246
-50.95%
|
-
|
|
Feb 14
2024
|
Douglas Fisher President |
BUY
Other acquisition or disposition
|
Direct |
43,300
+50.0%
|
-
|